Ignite Creation Date:
2024-05-06 @ 12:46 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01658436
Status:
COMPLETED
Last Update Posted:
2016-05-02
First Post:
2012-07-06
Brief Title:
BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors pNET After Failure of mTOR Inhibitor Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis